E
Evolva
Provides products that can contribute to health, wellbeing and sensory enjoyment
About Evolva
Evolva, founded in 2004, is a Swiss biotechnology company that focuses on the research, development, and commercialization of natural ingredients for a variety of industries.
The company's core business revolves around its proprietary fermentation platform, which allows for the sustainable and scalable production of high-value ingredients that are traditionally sourced from plants or animals. This approach offers an alternative to synthetic ingredients and addresses the growing consumer demand for natural and sustainable products.
Evolva serves a broad range of markets, including the food and beverage, flavor and fragrance, and health and wellness sectors. Its product portfolio includes ingredients like nootkatone (a citrus flavor and fragrance), resveratrol (a polyphenol with antioxidant properties), and vanillin (a key component of vanilla flavor). The company collaborates with other businesses to develop and commercialize new ingredients, leveraging its technology platform to create customized solutions.
The business model is based on a combination of product sales, milestone payments from collaborations, and royalties on the sales of products containing its ingredients. By offering a sustainable and cost-effective production method, Evolva aims to capture a significant share of the growing market for natural ingredients.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2004
- Headquarters
- Reinach, Switzerland
- Listing
- IPO 2005
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Andrea Jansen
Dario Fazlic
Adrian Bührer
US Centers for Disease Control and Prevention
Series A2 investors entered at this stage
Aravis Ventures
Novartis Venture Fund
Series B and later8 investors entered at this stage
Heartcore CapitalVinci Capital
Auriga Partners
Swisscom Ventures
Wellington Partners
BioMedVC
Entrepreneurs Fund
Nice&Green SA
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Evolva on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Evolva on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.